Content area

Abstract

Abstract.

Alzheimer’s disease (AD) is a neurodegenerative disorder associated with cognitive and behavioral dysfunction and is the leading cause of dementia in the elderly. Several studies have implicated molecular and cellular signaling cascades involving the serine-threonine kinase, glycogen synthase kinase β(GSK-3β) in the pathogenesis of AD. GSK-3β may play an important role in the formation of neurofibrillary tangles and senile plaques, the two classical pathological hallmarks of AD. In this review, we discuss the interaction between GSK-3β and several key molecules involved in AD, including the presenilins, amyloid precursor protein, tau, and β-amyloid. We identify the signal transduction pathways involved in the pathogenesis of AD, including Wnt, Notch, and the PI3 kinase/Akt pathway. These may be potential therapeutic targets in AD.

Details

Title
Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance
Pages
1226-1235
Publication year
2006
Publication date
Jun 2006
Publisher
Springer Nature B.V.
ISSN
1420-682X
e-ISSN
1420-9071
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
346784324
Copyright
Copyright Springer Nature B.V. Jun 2006